ARE QUADRUPLE LEVOFLOXACIN-BASED REGIMENS AN EFFECTIVE ALTERNATIVE TO STANDARD SEQUENTIAL THERAPY IN THE ERADICATION OF HELICOBACTER PYLORI?

被引：0
|
作者：
Branquinho, D. [1 ]
Almeida, N. [1 ]
Fernandes, A. [1 ]
Casela, A. [1 ]
Pina Cabral, J. [1 ]
Gregorio, C. [1 ]
Donato, M. [1 ]
Calhau, C. [1 ]
Romaozinho, J. [1 ]
Sofia, C. [1 ]
机构：
[1] Coimbra Univ Hosp, Coimbra, Portugal
来源：
HELICOBACTER | 2015年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P02.20
引用
收藏
页码：95 / 95
页数：1
相关论文
共 50 条
  • [11] A third-line levofloxacin-based rescue therapy for Helicobacter pylori eradication
    Zullo, A
    Hassan, C
    De Francesco, V
    Lorenzetti, R
    Marignani, M
    Angeletti, S
    Ierardi, E
    Morini, S
    [J]. DIGESTIVE AND LIVER DISEASE, 2003, 35 (04) : 232 - 236
  • [12] Helicobacter pylori eradication rate of levofloxacin-based therapy as third-line therapy
    Kang, M.
    Lee, S.
    Goo, E.
    Kim, K.
    Jang, B.
    Yang, C.
    [J]. HELICOBACTER, 2017, 22
  • [13] Efficacy of levofloxacin-based third-line therapy for the eradication of Helicobacter pylori in Seoul
    Lee, D.
    [J]. HELICOBACTER, 2019, 24
  • [14] Sequential therapy for Helicobacter pylori eradication: is levofloxacin better?
    Zullo, A.
    De Francesco, V.
    Vaira, D.
    [J]. GUT, 2011, 60 (11) : 1604 - 1604
  • [15] Clinical trial:: levofloxacin-based quadruple therapy was inferior to traditional quadruple therapy in the treatment of resistant Helicobacter pylori infection
    Yee, Y. K.
    Cheung, T. K.
    Chu, K.-M.
    Chan, C. K.
    Fung, J.
    Chan, P.
    But, D.
    Hung, I.
    Chan, A. O. O.
    Yuen, M. F.
    Hsu, A.
    Wong, B. C. Y.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 26 (07) : 1063 - 1067
  • [16] Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication
    Nista, Enrico C.
    Candelli, Marcello
    Zocco, Maria A.
    Cremonini, Filippo
    Ojetti, Veronica
    Finizio, Rosalba
    Spada, Cristiano
    Cammarota, Giovanni
    Gasbarrini, Giovanni
    Gasbarrini, Antonio
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : 1985 - 1990
  • [17] Comparison of 10-day levofloxacin bismuth-based quadruple therapy and levofloxacin-based triple therapy for Helicobacter pylori
    Wu, Tzung-Shiun
    Hsu, Ping-I
    Kuo, Chao-Hung
    Hu, Huang-Ming
    Wu, I-Chen
    Wang, Sophie S. W.
    Chen, Yen-Hsu
    Wu, Deng-Chyang
    Su, Wei-Wen
    Kuo, Fu-Chen
    [J]. JOURNAL OF DIGESTIVE DISEASES, 2017, 18 (09) : 537 - 542
  • [18] LEVOFLOXACIN/AMOXICILLIN-BASED REGIMENS VERSUS QUADRUPLE THERAPY FOR HELICOBACTER PYLORI ERADICATION IN SECOND-LINE: A METANALYSIS
    Di Caro, S.
    Fini, L.
    Daoud, Y.
    Laghi, L.
    Gasbarrini, A.
    Mccartney, S.
    Bloom, S.
    [J]. DIGESTIVE AND LIVER DISEASE, 2011, 43 : S161 - S161
  • [19] Rifaximin Plus Levofloxacin-Based Rescue Regimen for the Eradication of Helicobacter pylori
    Yun, Sang-Pil
    Seon, Han Gyung
    Ok, Chang Soo
    Yoo, Kwang Ho
    Kang, Min Kyung
    Kim, Won Hee
    Kwon, Chang Ii
    Ko, Kwang Hyun
    Hwang, Seong Gyu
    Park, Pil Won
    Hong, Sung Pyo
    [J]. GUT AND LIVER, 2012, 6 (04) : 452 - 456
  • [20] Levofloxacin Based Sequential and Triple Therapy Compared with Standard Plus Probiotic Combination for Helicobacter Pylori Eradication
    Ozdil, Kamil
    Calhan, Turan
    Sahin, Abdurrahman
    Senates, Ebubekir
    Kahraman, Resul
    Yuzbasioglu, Bilgehan
    Demirdag, Hakan
    Demirsoy, Huseyin
    Sokmen, H. Mehmet
    [J]. HEPATO-GASTROENTEROLOGY, 2011, 58 (109) : 1148 - 1152
12345